Vanda Pharmaceuticals Inc.
Vanda Pharmaceuticals Inc. (VNDA) — Form 8-K: Current report
About this filing
Vanda Pharmaceuticals Inc. (VNDA) filed an 8-K on Oct 28, 2026 reporting results of operations (earnings) (Item 2.02), with exhibits (Item 9.01).
Key facts
- Item 2.02 · Results of operations (earnings)
- Item 9.01 · Financial statements and exhibits
More VNDA filings
- SC 13G/A
Filed Nov 13, 2026
- 4
Filed Nov 5, 2026
- 10-Q
Filed Oct 29, 2026
- SC 13G
Filed Oct 27, 2026
- SC 13G/A
Filed Oct 9, 2026
- SC 13G
Filed Aug 19, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.